advertisement

---

Journal of Ocular Pharmacology and Therapeutics 18

Showing records 1 to 18 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

70115 Ocular Purine Receptors as Drug Targets in the Eye
Jacobson KA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 534-547

---

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Lavik E
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Laties A
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Sharma M
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573

---

70510 Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost
Yoo R; Choi YA
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 57-61

---

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Bhowmick R
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573

---

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kuehn MH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Rich CC
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---

70115 Ocular Purine Receptors as Drug Targets in the Eye
Civan MM
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 534-547

---

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Shoffstall AJ
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649

---

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Gappa-Fahlenkamp H
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Stoltz R
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---

70510 Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost
Cho BJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 57-61

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Humbert V
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Atkins K; Dumitrescu AV
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Brickman C; McVicar W
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kwon YH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649

---

69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Baumgartner RA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554

---